Irmela Jeremias

Irmela Jeremias

Helmholtz Zentrum Muenchen, Deutsches Forschungszentrum fuer Gesundheit und Umwelt - / Germany
Others
AD Scientific Index ID: 4432145
person_outline Irmela Jeremias's MOST POPULAR ARTICLES
1-) Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemiaE Yankova, W Blackaby, M Albertella, J Rak, E De Braekeleer, ...Nature 593 (7860), 597-601, 20218322021
2-) The target landscape of clinical kinase drugsS Klaeger, S Heinzlmeir, M Wilhelm, H Polzer, B Vick, PA Koenig, ...Science 358 (6367), eaan4368, 20178202017
3-) CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neuronsA Martin-Villalba, I Herr, I Jeremias, M Hahne, R Brandt, J Vogel, ...Journal of Neuroscience 19 (10), 3809-3817, 19996141999
4-) TRAIL/Apo‐2‐ligand‐induced apoptosis in human T cellsI Jeremias, I Herr, T Boehler, KM DebatinEuropean journal of immunology 28 (1), 143-152, 19984101998
5-) TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κBH Ehrhardt, S Fulda, I Schmid, J Hiscott, KM Debatin, I JeremiasOncogene 22 (25), 3842-3852, 20033952003